首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1671842

合約臨床研究組織市場：按服務類型、臨床監測、治療領域、最終用戶和地區分類

Contract Clinical Research Organization Market, By Service Type, Clinical Monitoring, By Therapeutic Area, By End User, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球合約臨床研究組織市場規模預計為 877.1 億美元，預計到 2032 年將達到 1,655.6 億美元，2025 年至 2032 年的複合年成長率為 9.5%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	877.1億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	9.50％	2032 年價值預測	1655.6億美元

數字。 2025 年合約臨床研究組織市場佔有率（按地區）

過去幾年，全球合約臨床研究組織（CRO）市場一直穩定成長。 CRO 是透過提供外包研究服務來支援製藥、生技和醫療設備業的公司。我們提供臨床試驗設計、資料管理、生物統計分析、監管服務等。藥物發現和研發過程的演變增加了製藥公司的研究的複雜性和成本，迫使他們將研究活動外包。此外，藥物開發週期的縮短也推動了對擁有跨各個治療領域專業知識和基礎設施的外部服務供應商的需求。這些因素極大地推動了合約臨床研究組織市場的成長。

市場動態：

製藥公司不斷增加的研發支出和日益採用外包策略正在極大地推動全球合約臨床研究組織市場的發展。此外，對專業臨床試驗服務的需求不斷成長以及先進技術的快速發展正在為該市場創造新的機會。然而，嚴格的法規和延遲的核准時間帶來了重大挑戰。此外，知識產權（IP）和資料安全相關的風險也在一定程度上抑制了市場的成長。製藥公司目前正在採用 CRO 的創新交付模式，以品質、專業知識和先進技術為驅動力，以獲得競爭優勢。預計這將在未來幾年開闢新的途徑。

本研究的主要特點

本報告對全球合約臨床研究組織市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。

該報告根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數，提供了全球合約臨床研究組織 (CRO) 市場主要企業的概況。

研究涉及的主要公司包括 IQVIA、Covance、Syneos Health、PPD（Pharmaceutical Product Development）、ICON plc、Charles River Laboratories、Medpace、Parexel International、WuXi AppTec、PRA Health Sciences、KCR、Celerion、Catalent、BioClinica 和 Clinicace。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過用於分析全球合約臨床研究組織市場的各種策略矩陣來簡化決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	US$ 87.71 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.50%	2032 Value Projection:	US$ 165.56 Bn

The global contract clinical research organization market has been witnessing steady growth over the past few years. CROs are companies that support the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. They provide clinical trial design, data management, biostatistical analysis, regulatory affairs services, and other services. The evolution of drug discovery and development processes has increased research complexities and costs for pharmaceutical companies, compelling them to outsource their research activities. Moreover, abbreviated drug development cycles have increased the demand for external service providers having expertise and infrastructure across varied therapeutic areas. These factors have boosted the contract clinical research organization market growth significantly.

Market Dynamics:

Rising research and development (R&D) expenditure of pharmaceutical companies along with higher adoption of outsourcing as a strategy is significantly driving the global contract clinical research organization market. Moreover, increasing demand for specialized clinical trial services and rapid evolution of advanced technologies are creating new opportunities in this market. However, stringent regulations and slower approval timelines pose major challenges. Additionally, the intellectual property (IP) rights and data security related risks restrain market growth to some extent. Pharmaceutical companies are now adopting innovative delivery models from CROs driven by quality, expertise, and advanced technologies to gain competitive advantage. This is expected to open up new avenues over the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global contract clinical research organization market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global contract clinical research organization (CRO) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IQVIA, Covance, Syneos Health, PPD (Pharmaceutical Product Development), ICON plc, Charles River Laboratories, Medpace, Parexel International, WuXi AppTec, PRA Health Sciences, KCR, Celerion, Catalent, BioClinica, and Clinipace

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global contract clinical research organization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract clinical research organization market

Market Segmentation

Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Clinical Trial Service
- Phase III
- Phase II
- Phase I
- Phase IV
- Clinical Monitoring
- Site Monitoring
- Data Monitoring
- Early phase development Services
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
- Laboratory Services
- Analytical Testing Services
- Bioanalytical Testing Services
- Regulatory Affairs Services
Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Other Therapeutic Areas
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Research & Academic Institutions
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- IQVIA
- Covance
- Syneos Health
- PPD (Pharmaceutical Product Development)
- ICON plc
- Charles River Laboratories
- Medpace
- Parexel International
- WuXi AppTec
- PRA Health Sciences
- KCR
- Celerion
- Catalent
- BioClinica
- Clinipace

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Contract Clinical Research Organization Market, By Service Type
- Global Contract Clinical Research Organization Market, By Therapeutic Area
- Global Contract Clinical Research Organization Market, By End User
- Global Contract Clinical Research Organization Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Contract Clinical Research Organization Market, By Service Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Clinical Trial Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Phase III
- Phase II
- Phase I
- Phase IV
Clinical Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Site Monitoring
- Data Monitoring
Early phase development Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
Laboratory Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Analytical Testing Services
- Bioanalytical Testing Services
Regulatory Affairs Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Contract Clinical Research Organization Market, By Therapeutic Area, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Therapeutic Areas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Contract Clinical Research Organization Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research & Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contract Clinical Research Organization Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

IQVIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covance
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PPD (Pharmaceutical Product Development)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PRA Health Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Celerion
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Catalent
BioClinica
Clinipace